0.618
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.6231
Aprire:
$0.605
Volume 24 ore:
227.10K
Relative Volume:
0.14
Capitalizzazione di mercato:
$2.20M
Reddito:
-
Utile/perdita netta:
$-9.64M
Rapporto P/E:
-0.0893
EPS:
-6.9236
Flusso di cassa netto:
$-10.11M
1 W Prestazione:
-7.32%
1M Prestazione:
-3.23%
6M Prestazione:
-73.48%
1 anno Prestazione:
-79.74%
Gt Biopharma Inc Stock (GTBP) Company Profile
Nome
Gt Biopharma Inc
Settore
Industria
Telefono
(800) 304-9888
Indirizzo
505 MONTGOMERY STREET, SAN FRANCISCO
Confronta GTBP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| 0.2846 | 0 | 0 | 0 | 0 | 0.00 | |
|
MOBBW
Mobilicom Limited Warrants
|
2.50 | 4.21B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
19.99 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.825 | 217.47M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2288 | 502.27M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.3695 | 0 | 0 | 0 | 0 | 0.00 |
Gt Biopharma Inc Stock (GTBP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-02 | Iniziato | ROTH MKM | Buy |
| 2021-05-24 | Iniziato | H.C. Wainwright | Buy |
| 2021-04-13 | Iniziato | B. Riley Securities | Buy |
| 2021-03-17 | Iniziato | ROTH Capital | Buy |
Gt Biopharma Inc Borsa (GTBP) Ultime notizie
Will GT Biopharma Inc. bounce back from current supportWeekly Trend Recap & Technical Pattern Based Signals - newser.com
Combining machine learning predictions for GT Biopharma Inc.July 2025 Analyst Calls & Weekly Stock Breakout Alerts - newser.com
Real time breakdown of GT Biopharma Inc. stock performance2025 Market Overview & Low Drawdown Momentum Ideas - newser.com
What institutional flow reveals about GT Biopharma Inc.July 2025 Opening Moves & Entry and Exit Point Strategies - newser.com
Understanding GT Biopharma Inc.’s price movementPortfolio Risk Report & Weekly Watchlist of Top Performers - newser.com
Short interest data insights for GT Biopharma Inc.2025 Top Gainers & Weekly High Return Stock Forecasts - newser.com
Evaluating GT Biopharma Inc. with trendline analysisWeekly Gains Summary & Safe Entry Point Identification - newser.com
Will GT Biopharma Inc. stock benefit from automation2025 Big Picture & Short-Term High Return Strategies - newser.com
Will GT Biopharma Inc. (OXIA) stock test record highs in 2025Analyst Downgrade & Risk Managed Investment Signals - newser.com
Is GT Biopharma Inc. stock ready for breakoutJuly 2025 Trade Ideas & Safe Capital Growth Plans - newser.com
Using R and stats models for GT Biopharma Inc. forecastingJuly 2025 Intraday Action & Low Drawdown Investment Strategies - newser.com
Can GT Biopharma Inc. stock sustain free cash flow growthJuly 2025 Catalysts & High Accuracy Swing Trade Signals - newser.com
GT Biopharma Retail Chatter Soars Most Among Biotechs After Financing Strategy Tweak - MSN
News impact scoring models applied to GT Biopharma Inc.2025 Market Outlook & Fast Entry and Exit Trade Plans - newser.com
EBITDA of GT Biopharma, Inc. – BOATS:GTBP - TradingView
GT Biopharma, Inc. (GTBP) Analyst insights, Price targets and Recommendations - Yahoo! Finance Australia
GT Biopharma, Inc. (GTBP) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Applying chart zones and confluence areas to GT Biopharma Inc.M&A Rumor & AI Driven Price Forecasts - newser.com
Tools to monitor GT Biopharma Inc. recovery probabilityQuarterly Growth Report & Free Safe Capital Growth Stock Tips - newser.com
Analyzing recovery setups for GT Biopharma Inc. investorsSell Signal & Real-Time Buy Zone Alerts - newser.com
Gt Biopharma Inc Azioni (GTBP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):